Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Merck KGaA Q2 Loss Reduces; Boosts Annual Outlook - Quick Facts

German drugs and chemicals firm Merck KGaA (MKGAY.PK) reported a narrower second-quarter 2012 loss after tax of 60.5 million euros, compared with 86.8 million euros last year. On a reported basis, quarterly loss per share was 0.29 euros, narrower than a 0.41 euros loss a year before, the company added. Adjusted for one-time costs, earnings per share pre totaled 1.92 euros, up 20% from the prior year's 1.60 euros.

Merck's second-quarter total revenues rose 12% to 2.85 billion euros, from 2.555 billion euros in the 2011 second quarter. Quarterly sales went up 11% to 2.74 billion euros, from 2.47 billion euros in the year-ago quarter, reflecting an organic sales growth of 5.1%, a 5.4% positive benefit from foreign exchange rates and a 0.5% rise from acquisitions and divestments.

Based on the second-quarter results, Merck has upgraded its full-year total revenues and EBITDA pre guidance for 2012. The company now sees annual EBITDA pre one-time items of 2.85 billion euros - 2.95 billion euros, and total revenues of around 10.7 billion euros. Previously, Merck Group estimated EBITDA pre one-time items of 2.8 billion euros - 2.9 billion euros, and total revenues of about 10.5 billion euros for 2012.

Click here to receive FREE breaking news email alerts for Merck KGaA and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Germany consumer confidence is set to improve further in August to the strongest level since December 2006 despite escalating geopolitical tensions in Israel and Ukraine, data from market research group GfK showed Friday. The forward-looking consumer sentiment index rose to 9 in August, while it was expected to remain unchanged at 8.9. This was the highest value recorded since December 2006. Amazon.com, Inc. said Thursday that its second quarter loss widened from last year, as operating expenses outpaced revenue growth amid heavy spending on new technology and contents. The company's quarterly loss per share was also wider than what analysts expected, but is quarterly sales came in line with analysts' forecast. The company also forecast an operating loss for the current quarter. After failing to sustain an initial upward move, stocks showed a lack of direction throughout much of the trading day on Thursday. The major averages eventually closed nearly unchanged, turning in a mixed performance for the second straight day.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.